CBD Boosts Anti-Inflammatory Lipid Production in Humans, THC Does Not
Human clinical data showed high-CBD cannabis increased anti-inflammatory lipid mediators, particularly lipoxins, while high-THC cannabis did not produce the same effect.
Quick Facts
What This Study Found
Using plasma data from multiple clinical studies, high-CBD cannabis use led to increased levels of anti-inflammatory eicosanoids, particularly lipoxins produced through the 15-LOX pathway. High-THC cannabis did not produce similar increases in these anti-inflammatory mediators.
Key Numbers
High-CBD cannabis increased lipoxin levels via the 15-LOX pathway. High-THC cannabis showed no similar increase. Eicosanoid levels measured across LOX, COX, and CYP450 pathways.
How They Did This
Analysis of plasma samples from multiple clinical studies comparing the effects of high-CBD versus high-THC cannabis on eicosanoid levels generated through LOX, COX, and CYP450 pathways.
Why This Research Matters
This is rare human-level evidence showing how CBD produces anti-inflammatory effects at the molecular level, specifically through lipid mediator pathways, supporting its therapeutic potential for inflammatory diseases.
The Bigger Picture
Most CBD anti-inflammatory evidence comes from cell and animal studies. This human data identifies the specific lipid mediator pathway through which CBD works, providing a mechanistic foundation for clinical applications.
What This Study Doesn't Tell Us
Pooled data from multiple studies introduces variability. Cannot control for all differences between study populations. Specific CBD and THC doses varied. Plasma levels may not reflect tissue-level effects.
Questions This Raises
- ?What CBD dose maximizes lipoxin production?
- ?Could CBD replace NSAIDs for inflammation?
- ?Does the 15-LOX pathway explain CBD benefits in specific inflammatory diseases?
Trust & Context
- Key Stat:
- CBD increased anti-inflammatory lipoxins in humans; THC did not
- Evidence Grade:
- Human plasma data from clinical studies, but pooled design introduces variability.
- Study Age:
- 2025 analysis of human clinical trial plasma samples.
- Original Title:
- Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans.
- Published In:
- Cannabis and cannabinoid research, 10(4), 506-511 (2025)
- Authors:
- Morris, Alan W J(2), Mueller, Raeghan L(4), Sempio, Cristina(20), Klawitter, Jost, Bryan, Angela D, Bidwell, L Cinnamon, Hutchison, Kent E
- Database ID:
- RTHC-07190
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
How does CBD reduce inflammation?
This study found CBD increases the production of lipoxins, anti-inflammatory molecules made through the 15-LOX enzyme pathway. This is one of the first studies to demonstrate this mechanism in humans rather than just in lab experiments.
Is THC anti-inflammatory too?
In this study, high-THC cannabis did not increase anti-inflammatory lipid mediators the way CBD did, suggesting the two cannabinoids have different effects on inflammatory pathways.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07190APA
Morris, Alan W J; Mueller, Raeghan L; Sempio, Cristina; Klawitter, Jost; Bryan, Angela D; Bidwell, L Cinnamon; Hutchison, Kent E. (2025). Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans.. Cannabis and cannabinoid research, 10(4), 506-511. https://doi.org/10.1089/can.2024.0175
MLA
Morris, Alan W J, et al. "Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-Inflammatory Lipid Mediator Synthesis in Humans.." Cannabis and cannabinoid research, 2025. https://doi.org/10.1089/can.2024.0175
RethinkTHC
RethinkTHC Research Database. "Effect of Cannabidiol and Δ9-tetrahydrocannabinol on Anti-In..." RTHC-07190. Retrieved from https://rethinkthc.com/research/morris-2025-effect-of-cannabidiol-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.